why choose us

First received: July 13, 2023

Clinical Trial: A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).

Study Status: Completed

Recruit Status: RECRUITING

Condition: Pulmonary Arterial Hypertension

Study Type: INTERVENTIONAL


Official Title: A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hyp

Brief Summary: Study KER-012-A201 is Phase 2, double-blind, randomized, placebo-controlled study to determine the efficacy and safety of KER-012 compared to Placebo in adults with PAH (WHO Group 1 PH) on stable background PAH therapy.The study is divided into the Screening Period, Treatment Period, Extension Period, and Follow-Up Period.

Read more